Literature DB >> 6639453

Olfactory neuroblastoma. Biologic and clinical behavior.

K D Olsen, L W DeSanto.   

Abstract

The biologic behavior of olfactory neuroblastoma in 21 persons treated at the Mayo Clinic, Rochester, Minn, from 1960 to 1980 is reviewed. Follow-up data of five years or more are available for 19 cases. Findings showed the tendency of these tumors to spread submucosally and intracranially without obvious involvement of the anterior cranial fossa dura. The aggressive nature of this lesion has not been appreciated. Metastatic disease occurred in 62% and local recurrence in 57%. Long-term follow-up showed that recurrent or metastatic disease could occur up to ten years after initial diagnosis. The five-year survival rate was 58%. Only four patients who have been follow-up for more than five years were without local recurrence or metastasis. This review should prompt a change in the current attitudes toward treatment of this tumor.

Entities:  

Mesh:

Year:  1983        PMID: 6639453     DOI: 10.1001/archotol.1983.00800260019005

Source DB:  PubMed          Journal:  Arch Otolaryngol        ISSN: 0003-9977


  12 in total

Review 1.  Retropharyngeal lymph node metastasis from olfactory neuroblastoma: A report of two cases.

Authors:  Hyun Jik Kim; Jinna Kim; Joo-Heon Yoon
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-05-12       Impact factor: 2.503

2.  IMPROVED OUTCOME WITH MULTIMODAL MANAGEMENT OF ADVANCED ESTHESIONEUROBLASTOMA (Report of Two Cases).

Authors:  R Rang A Rao; S Mukherjee; P K Thakur; K S Suryanarayana; Y S Sarma; H G Mukhopadhyay
Journal:  Med J Armed Forces India       Date:  2017-06-26

3.  Aesthesioneuroblastoma of Nose.

Authors:  S C Gupta; A K Das; M D Venkatesh; R C Kashyap; S Bhattacharya
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 4.  Imaging Characteristics of Olfactory Neuroblastoma (Esthesioneuroblastoma).

Authors:  Arthur B Dublin; Matthew Bobinski
Journal:  J Neurol Surg B Skull Base       Date:  2015-09-14

Review 5.  The biology and pathology of selected skull base tumors.

Authors:  L Barnes; S B Kapadia
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

6.  The role of elective nodal irradiation for esthesioneuroblastoma patients with clinically negative neck.

Authors:  Wen Jiang; Abdallah S R Mohamed; Clifton David Fuller; Betty Y S Kim; Chad Tang; G Brandon Gunn; Ehab Y Hanna; Steven J Frank; Shirley Y Su; Eduardo Diaz; Michael E Kupferman; Beth M Beadle; William H Morrison; Heath Skinner; Stephen Y Lai; Adel K El-Naggar; Franco DeMonte; David I Rosenthal; Adam S Garden; Jack Phan
Journal:  Pract Radiat Oncol       Date:  2015-11-10

7.  Esthesioneuroblastoma treated with external radiotherapy. Case report.

Authors:  F Tramacere; S Bambace; M C De Luca; R Castagna; M C Francavilla; A Leone; S Monastero; F Fucilli; G Pili; M Portaluri
Journal:  Acta Otorhinolaryngol Ital       Date:  2008-08       Impact factor: 2.124

Review 8.  Chemotherapy for cranial base tumors.

Authors:  H E Jacob
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

Review 9.  Review of skull base surgery approaches: with special reference to pediatric patients.

Authors:  J D Kennedy; S J Haines
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

10.  Vertebral column metastases from an esthesioneuroblastoma: chemotherapy, radiation, and resection for recurrence with 15-year followup.

Authors:  Ali S Shirzadi; Doniel G Drazin; Allison S Strickland; Serguei I Bannykh; J Patrick Johnson
Journal:  Case Rep Surg       Date:  2013-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.